Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee
The next step in the process is for the FDA to decide whether to grant an EUA for Janssen's COVID-19 vaccine candidate.
- The next step in the process is for the FDA to decide whether to grant an EUA for Janssen's COVID-19 vaccine candidate.
- The recommendation of the FDA Advisory Committee is non-binding, and the final decision on authorization is made by the FDA.
- We are confident that our COVID-19 vaccine candidate will have a significant impact in protecting people around the world," said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, Johnson & Johnson.
- The Johnson & Johnson COVID-19 single-dose vaccine candidate is compatible with standard vaccine storage and distribution channels with ease of delivery to remote areas.